Dataset Information

COVID-19: the impact of a global crisis on sustainable development research.

ABSTRACT: The crisis caused by COVID-19 has affected research in a variety of ways. As far as research on sustainable development is concerned, the lockdown has significantly disrupted the usual communication channels and, among other things, has led to the cancellation of meetings and long-planned events. It has also led to delay in the delivery of research projects. There is a gap in the literature in regards to how a global crisis influences sustainability research. Therefore, this ground-breaking paper undertakes an analysis of the extent to which COVID-19 as a whole, and the lockdown in particular, has influenced sustainability research, and it outlines the solutions pursued by researchers around the world to overcome the many challenges they have experienced. This paper also outlines some measures that may be implemented in the future to take more advantage of existing technologies that support research on sustainable development.

SUBMITTER: Leal Filho W

PROVIDER: S-EPMC7649899 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

COVID-19: the impact of a global crisis on sustainable development research.

Leal Filho Walter W Azul Anabela Marisa AM Wall Tony T Vasconcelos Claudio R P CRP Salvia Amanda Lange AL do Paço Arminda A Shulla Kalterina K Levesque Vanessa V Doni Federica F Alvarez-Castañón Lorena L Mac-Lean Claudia C Avila Lucas Veiga LV Damke Luana Inês LI Castro Paula P Azeiteiro Ulisses M UM Fritzen Bárbara B Ferreira Paula P Frankenberger Fernanda F

Sustainability science 20201109 1

The crisis caused by COVID-19 has affected research in a variety of ways. As far as research on sustainable development is concerned, the lockdown has significantly disrupted the usual communication channels and, among other things, has led to the cancellation of meetings and long-planned events. It has also led to delay in the delivery of research projects. There is a gap in the literature in regards to how a global crisis influences sustainability research. Therefore, this ground-breaking pape ...[more]

PMID: 33193904

Similar Datasets

Project description:This themed issue on global health research has come at an opportune time in the middle of the ongoing global public health crisis arising from the coronavirus disease (COVID-19) pandemic which has claimed nearly 756,000 lives in 210 countries and territories around the world as of August 15, 2020. The public health crisis underscores the importance of global health research partnerships and collaborations to develop and evaluate the requisite health technologies to assist in containing COVID-19, other diseases, and health-related concerns that defy national borders. The 17 Sustainable Development Goals (SDGs), adopted by the member countries of the United Nations in September 2015, provide a framework for global development efforts including global health research. SDG3, which promotes health and well-being for the world populations across the age spectrum, highlights disease areas for special focus which can be adapted in specific global health research programs to serve local health needs. SDG17 promotes partnerships between high income (HIC) and low and middle-income countries (LMIC) for sustainable and equitable global development. However, given the wide disparities in fiscal and overall capacity for research between researchers in HIC and their counterparts in LMIC as well as the greater vulnerabilities of the LMIC communities when serving as research locations, a spotlight on the nature of such global health research partnerships in the context of the SDGs is desirable. This is to ensure that they are meaningful and mutually-beneficial partnerships which address local health concerns and promote long-term value for the communities involved. The objective of this commentary is, therefore, to provide a brief overview of the SDGs by way of context; explore the power differences at play when researchers from HIC are seeking research opportunities in LMIC; examine the social determinants of health and the disproportionate burden of global diseases carried by populations in LMIC to establish their vulnerability; discuss global research partnerships; and attempt to make a case for why community-based participatory research may be the preferred type of global health research partnership in the context of the SDGs.

Project description:BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has spread throughout more than 160 countries, infecting millions of people worldwide. To address this health emergency, countries have organized the flow of production and innovation to reduce the impact on health. This article shows the response of the Brazilian scientific community to meet the urgent needs of the public unified health system [SUS], aiming to guarantee universal access to an estimated population of 211 million. By December 2020, Brazil had recorded more than six million cases and approximately 175,000 deaths.MethodsWe collected data on research, development and innovation projects carried out by 114 public universities (plus Oswaldo Cruz Foundation [Fiocruz] and Butantan Institute), as reported on their websites. Additionally, we examined the studies on COVID-19 approved by the National Comission for Research Ethics, as well as those reported on the Ministry of Education website as of May 15, 2020.ResultsThe 789 identified projects were classified according to research categories as follows: development and innovation (n = 280), other types of projects (n = 226), epidemiologic research (n = 211), and basic research on disease mechanisms (n = 72). Most proposals focused on the development and innovation of personal protective equipment, medical devices, diagnostic tests, medicines and vaccines, which were rapidly identified as research priorities by the scientific community. Some promising results have been observed from phase III vaccine trials, one of which is conducted in partnership with Oxford University and another of which is performed with Sinovac Biotech. Both trials involve thousands of volunteers in their Brazilian arms and include technology transfer agreements with Fiocruz and the Butantan Institute, respectively. These vaccines proved to be safe and effective and were immediately licensed for emergency use. The provision of doses for the public health system, and vaccination, started on January 17, 2021.ConclusionsThe mobilized Brazilian scientific community has generated comprehensive research, development and innovation proposals to meet the most urgent needs. It is important to emphasize that this response was only possible due to decades of investment in research, development and innovation in Brazil. We need to reinforce and protect the Brazilian science, technology and innovation system from austerity policies that disregard health and knowledge as crucial investments for Brazilian society, in line with the constitutional right of universal health access and universal health coverage.

Dataset Information

COVID-19: the impact of a global crisis on sustainable development research.

Publications

COVID-19: the impact of a global crisis on sustainable development research.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets